Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2013

Feb 5, 2013

30016_dirs_2013-02-05_c81572e4-635d-437c-8b35-59edcf05de0a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-01

Reporting Person: Williams Michael J PhD (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-01 Common Stock M 7668 $53.3100 Acquired 17696 Direct
2013-02-01 Common Stock M 15764 $56.9500 Acquired 33460 Direct
2013-02-01 Common Stock S 23432 $94.6815 Disposed 10028 Direct
2013-02-01 Common Stock S 862 $94.9644 Disposed 9166 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-01 Non-Qualified Stock Option (right to buy) $53.3100 M 7668 Acquired 2017-02-13 Common Stock (7668) Direct
2013-02-01 Non-Qualified Stock Option (right to buy) $56.9500 M 15764 Acquired 2015-02-13 Common Stock (15764) Direct

Footnotes

F1: Includes 63 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 12/31/2012.

F2: Grant of options to buy shares of common stock becomes exercisable as to 3,834 shares on 02/14/2011, 02/14/2012, 02/14/2013 and 02/14/2014 and the remaining 1,959 shares on 02/14/2015.

F3: Grant of options to buy shares of common stock becomes exercisable as to 3,942 shares on 02/14/2009, 3,941 shares on 02/14/2010 and 02/14/2012, 3,940 shares on 02/14/2011 and the remaining 2,186 shares on 02/14/2013.